Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
96.3M
-
Shares change
-
+1.75M
-
Total reported value, excl. options
-
$3.06B
-
Value change
-
+$57.8M
-
Put/Call ratio
-
0.3
-
Number of buys
-
79
-
Number of sells
-
-82
-
Price
-
$31.75
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q4 2014
213 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q4 2014.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96.3M shares
of 170M outstanding shares and own 56.59% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (20.5M shares), FMR LLC (15M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.24M shares), VANGUARD GROUP INC (4.88M shares), BlackRock Fund Advisors (3.19M shares), Viking Global Investors LP (2.96M shares), JENNISON ASSOCIATES LLC (2.87M shares), JANUS CAPITAL MANAGEMENT LLC (2.65M shares), WADDELL & REED FINANCIAL INC (2.35M shares), and BlackRock Institutional Trust Company, N.A. (2.06M shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.